Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study

This publication has 32 references indexed in Scilit:

• Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis
  Annals of the Rheumatic Diseases, 2015
• Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
  Annals of the Rheumatic Diseases, 2014
• Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
  Annals of the Rheumatic Diseases, 2014
• Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
  The Lancet, 2013
• The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis
  BMC Musculoskeletal Disorders, 2013
• Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study
  Annals of the Rheumatic Diseases, 2012
• A randomized placebo-controlled trial of methotrexate in psoriatic arthritis
  Rheumatology, 2012
• Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis
  Annals of the Rheumatic Diseases, 2010
• Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment
  Annals of the Rheumatic Diseases, 2010
• Classification criteria for psoriatic arthritis: Development of new criteria from a large international study
  Arthritis & Rheumatism, 2006